Harmony Biosciences (HRMY) Tops Q1 EPS by 20c

Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.51, $0.20 better than the analyst estimate of $0.31. Revenue for the quarter came in at $85.3 million versus the consensus estimate of $89.61 million.

For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.

You May Also Be Interested In

• SpaceX: New Street Research sees 22% upside from proposed IPO price
• McGraw Hill (MH) Tops Q1 EPS by 15c, Beats on Revenue; Offers FY26 Revenue Guidance
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c